Pivotal bioVenture Partners Investment Advisor LLC
An institutional investment manager in SAN FRANCISCO, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1844645.
- Reported value$307.8m
- Positions13
Holdings: 13 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Vaxcyte IncPCVX | COM | 92243G108 | 82.9 | 26.9% | 1,425,470 | Added+53,045 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 33.2 | 10.8% | 1,265,283 | Reduced−90,609 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 32.5 | 10.6% | 1,742,672 | Added+188,946 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 31.8 | 10.3% | 966,792 | New+966,792 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 25.6 | 8.3% | 1,926,943 | Unchanged | |
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 21.9 | 7.1% | 611,446 | Reduced−1 | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 20.9 | 6.8% | 1,506,250 | Reduced−174,033 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 16.0 | 5.2% | 653,374 | Unchanged | |
| Immunome IncIMNM | COM | 45257U108 | 15.5 | 5.0% | 732,512 | Unchanged | |
| Zenas Biopharma IncZBIO | COM | 98937L105 | 12.5 | 4.0% | 490,766 | Reduced−101,225 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 8.0 | 2.6% | 434,033 | Added+138,100 | |
| Rallybio CorpRLYB | COM | 75120L209 | 4.8 | 1.6% | 300,579 | Unchanged | |
| Recursion Pharmaceuticals inRXRX | CL A | 75629V104 | 2.2 | 0.7% | 595,518 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics IncBOLT | COM NEW | 097702203 | 0.0 | 0.0% | 0 | Sold out−42,581 |
Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000759 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.